To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene TBC1D16TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
403 supporting clones for gene TBC1D16 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
CN361974 embryonic stem cells, cell lines H1, H7, andH9 .a 1 to 558 5 to 558   tiling clone,   558/558
(100 %)
7 diff
(98.8 %id)
CR992291 T-Lymphocytes .a 18 to 656 1 to 639       639/641
(99 %)
1 diff
(99.9 %id)
BC028290 Bladder, transitional cell papilloma .a 20 to 3276 1 to 3257 exact tiling clone, available from MGC, AAA   3257/3257
(100 %)
1 diff
(100.0 %id)
NM_019020.2   .a 20 to 3276 1 to 3257 exact RefSeq, AAA   3257/3257
(100 %)
1 diff
(100.0 %id)
BG260894 bladder, transitional cell papilloma, cell line .a 21 to 731 1 to 709       709/890
(79 %)
25 diff
(97.2 %id)
BI914395 brain .a 28 to 733 1 to 708       708/708
(100 %)
18 diff
(97.5 %id)
TI_57242080   .a 28 to 733 31 to 738       708/738
(95 %)
24 diff
(96.8 %id)
BE619300 large cell carcinoma, lung .a 30 to 703 1 to 665       665/837
(79 %)
32 diff
(96.2 %id)
CN361975 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 84 to 399 1 to 316       316/316
(100 %)
3 diff
(99.1 %id)
CN361976 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 123 to 562 1 to 440       440/440
(100 %)
0 diff
(100 %id)
AB449902 brain .a 136 to 2439 1 to 2304 exact     2304/2304
(100 %)
0 diff
(100 %id)
BX390618   .a 1271 to 2166 1 to 896       896/897
(99 %)
18 diff
(98.0 %id)
BU188399 melanotic melanoma, skin .a 1280 to 2125 6 to 862       857/881
(97 %)
22 diff
(97.6 %id)
BF856776 prostate_tumor .a 1399 to 1799 400 to 1     Submitted on the opposite strand 400/400
(100 %)
1 diff
(99.8 %id)
BG764349 melanotic melanoma, high MDR (cell line), skin .a 1410 to 2234 1 to 822       822/850
(96 %)
13 diff
(98.5 %id)
AA401132 ovarian tumor, ovary .a 1497 to 1595 1 to 99     Submitted on the opposite strand 99/99
(100 %)
1 diff
(99.0 %id)
AA405167 ovarian tumor, ovary .a 1507 to 1626 123 to 4     Submitted on the opposite strand 120/123
(97 %)
0 diff
(100 %id)
BF366844 nervous_tumor .a 1547 to 1790 248 to 13       236/248
(95 %)
0 diff
(100 %id)
TI_57193473   .a 1611 to 2299 45 to 733       689/689
(100 %)
0 diff
(100 %id)
BI862132 breast, mammary adenocarcinoma, cell line .a 1612 to 2299 1 to 688       688/688
(100 %)
0 diff
(100 %id)
BG576098 breast, mammary adenocarcinoma, cell line .a 1615 to 2326 1 to 715       715/715
(100 %)
11 diff
(98.5 %id)
BG577099 breast, mammary adenocarcinoma, cell line .a 1803 to 2588 1 to 792       792/953
(83 %)
28 diff
(97.1 %id)
CB217153 normal endometrium, mid-secretory phase,cycle day 23, uterus .a 1838 to 2475 1 to 638       638/638
(100 %)
0 diff
(100 %id)
BG291025 bladder, transitional cell papilloma, cell line .a 2047 to 2787 1 to 730       730/962
(75 %)
19 diff
(98.1 %id)
TI_59393169   .a 2064 to 2764 89 to 788       700/700
(100 %)
13 diff
(98.2 %id)
BM015059 breast, mammary adenocarcinoma, cell line .a 2065 to 2764 1 to 699       699/699
(100 %)
13 diff
(98.2 %id)
BG033170 breast, mammary adenocarcinoma, cell line .a 2123 to 2827 1 to 699       699/940
(74 %)
10 diff
(99.0 %id)
CN296325 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 2133 to 2705 1 to 573       573/573
(100 %)
3 diff
(99.5 %id)
BQ212711 melanotic melanoma, skin .a 2366 to 2952 1 to 595       595/921
(64 %)
13 diff
(98.6 %id)
BQ220599 melanotic melanoma, skin .a 2528 to 3123 1 to 606   tiling clone,   606/1053
(57 %)
30 diff
(97.2 %id)
BU845125 ovary, teratocarcinoma, cell line .a 2538 to 3426 1 to 895       895/924
(96 %)
13 diff
(98.6 %id)
BU167446 melanotic melanoma, skin .a 2550 to 3148 1 to 601       601/815
(73 %)
20 diff
(97.6 %id)
AI935521 Kidney .a 2563 to 3006 445 to 1       445/445
(100 %)
1 diff
(99.8 %id)
DB293145   .a 2578 to 3373 2 to 798   capped   797/799
(99 %)
14 diff
(98.3 %id)
BG764042 melanotic melanoma, high MDR (cell line), skin .a 2637 to 2766 1 to 130       130/130
(100 %)
1 diff
(99.3 %id)
BG766587 melanotic melanoma, high MDR (cell line), skin .a 2637 to 3280 1 to 655       655/766
(85 %)
28 diff
(96.4 %id)
BG767535 melanotic melanoma, high MDR (cell line), skin .a 2637 to 3186 1 to 552       552/552
(100 %)
3 diff
(99.5 %id)
BG767966 melanotic melanoma, high MDR (cell line), skin .a 2637 to 3252 1 to 617       617/618
(99 %)
4 diff
(99.4 %id)
BU632217 cell lines, Chondrosarcoma .a 2637 to 3276 658 to 19   AAA   640/640
(100 %)
1 diff
(99.9 %id)
BG769193 melanotic melanoma, high MDR (cell line), skin .a 2638 to 3377 1 to 742       742/743
(99 %)
15 diff
(98.0 %id)
BE619911 large cell carcinoma, lung .a 2641 to 3209 596 to 8       589/1015
(58 %)
0 diff
(100 %id)
BE007840 breast_normal .a 2660 to 3040 1 to 380       380/380
(100 %)
2 diff
(99.5 %id)
CN296324 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 2673 to 3198 1 to 526       526/526
(100 %)
1 diff
(99.9 %id)
AA039606 uterus .a 2685 to 3006 329 to 1       329/329
(100 %)
10 diff
(97.0 %id)
BX472634   .a 2694 to 3281 1 to 588       588/588
(100 %)
1 diff
(99.9 %id)
AI431804 Kidney .a 2760 to 3179 439 to 20   AAA   420/420
(100 %)
1 diff
(99.8 %id)
BQ929687 leiomyosarcoma, uterus .a 2761 to 3634 1 to 877       877/877
(100 %)
7 diff
(99.3 %id)
BF514357   .a 2778 to 3276 516 to 18   AAA   499/499
(100 %)
2 diff
(99.6 %id)
AW026037 Kidney .a 2779 to 3006 228 to 1       228/228
(100 %)
0 diff
(100 %id)
DB287570 uterus .a 2892 to 3462 2 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
AA434026 ovarian tumor, ovary .a 2900 to 3282 1 to 382       382/383
(99 %)
3 diff
(99.3 %id)
BE389777 endometrium, adenocarcinoma cell line, uterus .a 2957 to 3572 1 to 615   tiling clone,   615/699
(87 %)
11 diff
(98.5 %id)
BE389044 endometrium, adenocarcinoma cell line, uterus .a 2957 to 3445 1 to 490       490/491
(99 %)
7 diff
(98.6 %id)
BE385499 melanotic melanoma, skin .a 2957 to 3608 1 to 674       674/702
(96 %)
40 diff
(94.4 %id)
BG282472 melanotic melanoma, skin .a 3027 to 3788 84 to 838       755/889
(84 %)
30 diff
(96.7 %id)
CN296323 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 3075 to 3333 1 to 265       265/265
(100 %)
10 diff
(96.3 %id)
AK097283 Spleen .a 3111 to 5340 1 to 2230   tiling clone, available from FLJ,   2230/2230
(100 %)
3 diff
(99.9 %id)
DA950202 Spleen .a 3112 to 3681 2 to 573   capped   572/572
(100 %)
2 diff
(99.7 %id)
AI275239 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .a 3126 to 3278 153 to 1       153/153
(100 %)
1 diff
(99.4 %id)
CN296322 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 3148 to 3771 1 to 625       625/625
(100 %)
1 diff
(99.9 %id)
BM014056 breast, mammary adenocarcinoma, cell line .a 3149 to 3276 1 to 128   AAA   128/128
(100 %)
2 diff
(98.5 %id)
DA409356 thalamus .a 3196 to 3753 2 to 560   capped   559/559
(100 %)
3 diff
(99.5 %id)
DA105093 cerebellum .a 3197 to 3753 2 to 562   capped   561/561
(100 %)
4 diff
(99.3 %id)
BG769910 melanotic melanoma, high MDR (cell line), skin .a 3210 to 4082 1 to 870       870/873
(99 %)
27 diff
(97.0 %id)
BG769941 melanotic melanoma, high MDR (cell line), skin .a 3231 to 3300 623 to 693       508/768
(66 %)
39 diff
(95.0 %id)
BE390623 endometrium, adenocarcinoma cell line, uterus .a 3236 to 3863 4 to 632       629/714
(88 %)
6 diff
(99.2 %id)
BE391697 endometrium, adenocarcinoma cell line, uterus .a 3245 to 3838 57 to 653       597/653
(91 %)
6 diff
(99.1 %id)
DA569887 whole embryo, mainly head .a 3422 to 4290 2 to 870   capped   869/870
(99 %)
16 diff
(98.2 %id)
BQ425066 eye, retinoblastoma .a 3435 to 3949 1 to 524       524/905
(57 %)
21 diff
(97.7 %id)
BU170562 eye, retinoblastoma .a 3479 to 4149 1 to 676       676/869
(77 %)
18 diff
(98.0 %id)
BF837696 head_neck .a 3534 to 3677 1 to 147       147/153
(96 %)
9 diff
(94.2 %id)
DB061616 testis .a 3598 to 4169 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DA758918   .a 3602 to 4137 2 to 538   capped   537/537
(100 %)
1 diff
(99.9 %id)
AL121541 melanoma (MeWo cell line) .a 3657 to 4394 1 to 734       734/742
(98 %)
7 diff
(99.1 %id)
N49995 liver and spleen .a 3735 to 4229 1 to 495       495/497
(99 %)
2 diff
(99.6 %id)
BX471457   .a 3809 to 4349 1 to 540       540/545
(99 %)
3 diff
(99.5 %id)
DB227169 trachea .a 3814 to 4400 2 to 588   capped   587/587
(100 %)
0 diff
(100 %id)
BQ220169 melanotic melanoma, skin .a 3862 to 4661 1 to 814       814/923
(88 %)
26 diff
(97.2 %id)
N34595 melanocyte .a 3964 to 4389 1 to 428       428/428
(100 %)
3 diff
(99.3 %id)
DB228273 trachea .a 4019 to 4565 2 to 548   capped   547/547
(100 %)
0 diff
(100 %id)
BQ876987 epidermoid carcinoma, cell line, lung .a 4035 to 4748 1 to 720       720/886
(81 %)
25 diff
(97.2 %id)
BG337790 leiomyosarcoma cell line, uterus .a 4103 to 4947 1 to 850       850/902
(94 %)
41 diff
(95.5 %id)
BQ899284 dorsal root ganglia .a 4130 to 4953 1 to 832       832/977
(85 %)
16 diff
(98.4 %id)
BU931938 ovary, teratocarcinoma, cell line .a 4130 to 5026 1 to 900       900/900
(100 %)
7 diff
(99.3 %id)
DA126423 cerebellum .a 4205 to 4797 2 to 594   capped   593/593
(100 %)
2 diff
(99.7 %id)
BG334646 melanotic melanoma, skin .a 4272 to 4872 1 to 606       606/820
(73 %)
26 diff
(96.9 %id)
BG476050 melanotic melanoma, skin .a 4272 to 4678 1 to 407       407/902
(45 %)
11 diff
(98.8 %id)
BE410938 choriocarcinoma, placenta .a 4276 to 4960 11 to 688       678/751
(90 %)
6 diff
(99.3 %id)
BE384560 melanotic melanoma, skin .a 4292 to 4956 1 to 659       659/726
(90 %)
11 diff
(98.5 %id)
BM451213 eye, retinoblastoma .a 4413 to 5257 1 to 852   tiling clone,   852/853
(99 %)
13 diff
(98.5 %id)
CX163627 human embryonic stem cells differentiated toan early endodermal cell type .a 4472 to 5338 1 to 865       865/865
(100 %)
3 diff
(99.7 %id)
BQ322241 colon .a 4560 to 4892 4 to 336       333/340
(97 %)
9 diff
(97.4 %id)
CV420432 colon .a 4570 to 4892 1 to 327       327/331
(98 %)
14 diff
(95.8 %id)
BE707474 head_neck .a 4613 to 4892 291 to 12       280/291
(96 %)
0 diff
(100 %id)
BM695082 eye, human retina .a 4654 to 4966 1 to 313   fully sequenced,   313/313
(100 %)
0 diff
(100 %id)
DA474643   .a 4709 to 5270 2 to 563   capped   562/562
(100 %)
3 diff
(99.5 %id)
BU501023 eye, normal pigmented retinal epithelium .a 4726 to 5505 1 to 785       785/862
(91 %)
18 diff
(98.0 %id)
W00836 melanocyte .a 4730 to 5270 1 to 523       523/537
(97 %)
25 diff
(95.4 %id)
W02863 melanocyte .a 4742 to 5085 15 to 363       349/370
(94 %)
12 diff
(96.8 %id)
BI007917 kidney_tumor .a 4744 to 4924 192 to 12       181/192
(94 %)
0 diff
(100 %id)
DB356602 whole embryo, mainly head .a 4757 to 5340 584 to 1       584/586
(99 %)
18 diff
(97.0 %id)
TI_57191031   .a 4762 to 5531 55 to 830       776/776
(100 %)
15 diff
(98.1 %id)
BI857769 breast, mammary adenocarcinoma, cell line .a 4763 to 5531 1 to 775       775/775
(100 %)
15 diff
(98.1 %id)
DA743392   .a 4767 to 5285 2 to 520   capped   519/519
(100 %)
1 diff
(99.9 %id)
BU633458 cell lines, Chondrosarcoma .a 4792 to 5389 616 to 19   AAA   598/598
(100 %)
3 diff
(99.5 %id)
DR762247 embryonic stem .a 4794 to 5674 1 to 881       881/881
(100 %)
2 diff
(99.8 %id)
DB333729 Spleen .a 4807 to 5340 539 to 1       539/542
(99 %)
8 diff
(98.6 %id)
TI_151732162   .a 4812 to 5340 613 to 85   AAA   529/910
(58 %)
2 diff
(99.8 %id)
BQ188323 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 4815 to 5343 1 to 530   fully sequenced, AAA   530/530
(100 %)
4 diff
(99.3 %id)
BF027309 melanotic melanoma, skin .a 4835 to 5479 1 to 645       645/645
(100 %)
8 diff
(98.8 %id)
BG281542 melanotic melanoma, skin .a 4839 to 5610 1 to 777       777/892
(87 %)
27 diff
(97.0 %id)
BG282456 melanotic melanoma, skin .a 4839 to 5459 1 to 636       636/845
(75 %)
48 diff
(94.4 %id)
DB263714 uterus .a 4841 to 5401 2 to 562   capped   561/561
(100 %)
2 diff
(99.7 %id)
DB383085   .a 4859 to 5340 484 to 1       484/486
(99 %)
7 diff
(98.6 %id)
BE728525 melanotic melanoma, skin .a 4868 to 5615 12 to 757       746/784
(95 %)
26 diff
(96.7 %id)
N49891 liver and spleen .a 4878 to 5340 468 to 1       468/477
(98 %)
8 diff
(98.4 %id)
N26714 melanocyte .a 4888 to 5340 451 to 1       451/451
(100 %)
9 diff
(98.1 %id)
CD629602   .a 4921 to 5608 3 to 690       688/690
(99 %)
6 diff
(99.2 %id)
CD629604   .a 4921 to 5509 3 to 591       589/591
(99 %)
6 diff
(99.0 %id)
CD629601   .a 4928 to 5625 11 to 708   tiling clone,   698/712
(98 %)
4 diff
(99.5 %id)
BM666864 eye, human retina .a 4936 to 5340 423 to 19   fully sequenced, AAA   405/405
(100 %)
1 diff
(99.8 %id)
AI652499 pooled germ cell tumors .a 4946 to 5384 449 to 11       439/449
(97 %)
0 diff
(100 %id)
BE552326 pooled germ cell tumors .a 4946 to 5390 449 to 5       445/449
(99 %)
0 diff
(100 %id)
CD629605   .a 4995 to 5700 723 to 16       708/723
(97 %)
0 diff
(100 %id)
CK299810 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 5060 to 5340 299 to 19   fully sequenced, AAA   281/281
(100 %)
1 diff
(99.7 %id)
AW969436   .a 5069 to 5389 323 to 1     Submitted on the opposite strand 323/386
(83 %)
8 diff
(98.0 %id)
BG761284 melanotic melanoma, high MDR (cell line), skin .a 5093 to 5761 1 to 683       683/920
(74 %)
27 diff
(97.1 %id)
BM449869 melanotic melanoma, skin .a 5095 to 5806 1 to 715       715/926
(77 %)
6 diff
(99.4 %id)
DA208899 brain .a 5103 to 5675 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
AA494457 colon .a 5106 to 5389 295 to 11   AAA   285/285
(100 %)
2 diff
(99.3 %id)
BQ890520 melanotic melanoma, cell line, skin .a 5122 to 5900 1 to 794       794/980
(81 %)
20 diff
(98.0 %id)
BP227183   .a 5126 to 5706 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
DA056517 cerebellum .a 5136 to 5711 2 to 577   capped   576/576
(100 %)
3 diff
(99.5 %id)
DA780440 brain .a 5149 to 5726 2 to 580   capped   579/579
(100 %)
3 diff
(99.5 %id)
BG954761 colon .a 5199 to 5379 11 to 190       180/198
(90 %)
6 diff
(97.0 %id)
BG954255 colon .a 5209 to 5379 1 to 171       171/179
(95 %)
3 diff
(98.4 %id)
BU528713 epidermoid carcinoma, cell line, lung .a 5228 to 6076 1 to 860   available from MGC, AAA   860/860
(100 %)
14 diff
(98.4 %id)
BP239122 Liver .a 5237 to 5829 1 to 593       593/593
(100 %)
11 diff
(98.2 %id)
DA882588   .a 5306 to 5855 2 to 551   capped   550/550
(100 %)
1 diff
(99.9 %id)
DA868342 Prostate .a 5307 to 5864 2 to 560   capped   559/559
(100 %)
2 diff
(99.7 %id)
DA868139 Prostate .a 5320 to 5864 2 to 546   capped   545/545
(100 %)
3 diff
(99.5 %id)
AU280158   .a 5338 to 5854 1 to 517       517/517
(100 %)
2 diff
(99.7 %id)
BU179815 melanotic melanoma, cell line, skin .a 5363 to 5898 22 to 558       537/1161
(46 %)
16 diff
(98.7 %id)
BU179414 melanotic melanoma, cell line, skin .a 5366 to 6016 1 to 656   tiling clone,   656/918
(71 %)
22 diff
(97.7 %id)
BU145457 melanotic melanoma, cell line, skin .a 5366 to 6018 1 to 652       652/920
(70 %)
14 diff
(98.5 %id)
BQ683513 melanotic melanoma, cell line, skin .a 5366 to 5762 1 to 397       397/1015
(39 %)
7 diff
(99.4 %id)
CB155786 brain .a 5377 to 5904 1 to 529       529/529
(100 %)
2 diff
(99.7 %id)
AL699035 human skeletal muscle .a 5396 to 5756 1 to 362       362/362
(100 %)
3 diff
(99.2 %id)
BI860250 breast, mammary adenocarcinoma, cell line .a 5398 to 6044 1 to 649       649/649
(100 %)
24 diff
(96.4 %id)
TI_57189628   .a 5398 to 6044 50 to 698       649/649
(100 %)
24 diff
(96.4 %id)
CN421757 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 5426 to 5865 1 to 440       440/440
(100 %)
3 diff
(99.4 %id)
DA055445 cerebellum .a 5442 to 6014 2 to 574   capped   573/573
(100 %)
2 diff
(99.7 %id)
BF928626 nervous_tumor .a 5449 to 5611 1 to 163       163/163
(100 %)
7 diff
(95.8 %id)
BM466984 eye, retinoblastoma .a 5497 to 5976 1 to 480       480/1434
(33 %)
23 diff
(98.4 %id)
AI905060 breast .a 5541 to 5611 1 to 71       71/71
(100 %)
0 diff
(100 %id)
BM006717 ductal carcinoma, cell line, Pancreas .a 5596 to 6153 1 to 571   tiling clone,   571/658
(86 %)
32 diff
(95.2 %id)
BM006336 ductal carcinoma, cell line, Pancreas .a 5597 to 6021 1 to 422       422/443
(95 %)
9 diff
(98.0 %id)
TI_59395803   .a 5597 to 6153 65 to 634       570/657
(86 %)
32 diff
(95.2 %id)
TI_59394984   .a 5598 to 6021 93 to 513       421/442
(95 %)
8 diff
(98.2 %id)
BU196620 ductal carcinoma, cell line, Pancreas .a 5599 to 6138 1 to 540   tiling clone,   540/919
(58 %)
22 diff
(97.7 %id)
DA698680   .a 5630 to 6096 2 to 468   tiling clone, capped   467/467
(100 %)
1 diff
(99.8 %id)
BY795184 eye .a 5677 to 6018 1 to 342       342/571
(59 %)
2 diff
(99.7 %id)
BG424938 Kidney, renal cell adenocarcinoma .a 5678 to 6018 1 to 341       341/684
(49 %)
1 diff
(99.9 %id)
AK091923 Kidney .a 8136 to 10954 1 to 2819   tiling clone, available from FLJ,   2819/2819
(100 %)
8 diff
(99.8 %id)
AX747256   .a 8136 to 10954 1 to 2819       2819/2819
(100 %)
8 diff
(99.8 %id)
DA631919 Kidney .a 8137 to 8709 2 to 574   capped   573/573
(100 %)
2 diff
(99.7 %id)
BC062601 Breast, mammary adenocarcinoma. .a 8706 to 10954 1 to 2249   tiling clone, available from MGC, AAA   2249/2249
(100 %)
0 diff
(100 %id)
BG402890 bladder, transitional cell papilloma, cell line .a 9040 to 9832 1 to 778       778/968
(80 %)
25 diff
(97.5 %id)
BG820848 anaplastic oligodendroglioma with 1p/19qloss, brain .a 9091 to 9974 1 to 877       877/878
(99 %)
24 diff
(97.3 %id)
TI_151770396   .a 9444 to 10093 105 to 760       656/1085
(60 %)
8 diff
(99.3 %id)
BM555923 duodenal adenocarcinoma, cell line, small intestine .a 9597 to 10446 12 to 866       855/940
(90 %)
13 diff
(98.7 %id)
BF873108 lung_tumor .a 9654 to 10015 17 to 379       363/401
(90 %)
5 diff
(98.8 %id)
TI_151771632   .a 9673 to 10501 110 to 945       836/1056
(79 %)
25 diff
(97.7 %id)
CN310772 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 9705 to 10384 1 to 680       680/680
(100 %)
6 diff
(99.2 %id)
BX433136 brain, fetal brain .a 9792 to 10288 497 to 1       497/497
(100 %)
4 diff
(99.2 %id)
TI_154110613   .a 9939 to 10954 1051 to 61   AAA   991/1005
(98 %)
30 diff
(97.1 %id)
BE742285 adenocarcinoma cell line, ovary .a 9961 to 10753 1 to 790       790/793
(99 %)
19 diff
(97.7 %id)
BU178315 melanotic melanoma, skin .a 9971 to 10801 17 to 852       836/852
(98 %)
6 diff
(99.3 %id)
AA009875 heart .a 10002 to 10360 1 to 363       363/363
(100 %)
4 diff
(98.9 %id)
BG251901 adenocarcinoma, cell line, Liver .a 10039 to 10764 1 to 720       720/929
(77 %)
11 diff
(98.9 %id)
AA046336 uterus .a 10061 to 10267 12 to 221       210/221
(95 %)
5 diff
(97.8 %id)
BE786668 large cell carcinoma, lung .a 10079 to 10799 1 to 719       719/720
(99 %)
10 diff
(98.7 %id)
FN072156 breast carcinoma .a 10133 to 10211 1 to 80       80/80
(100 %)
2 diff
(97.5 %id)
CB054270 brain, glioblastoma (pooled) .a 10143 to 10430 1 to 288   fully sequenced,   288/288
(100 %)
5 diff
(98.3 %id)
BX114673 heart .a 10147 to 10944 1 to 798   AAA   798/798
(100 %)
5 diff
(99.4 %id)
W94396 heart .a 10147 to 10503 1 to 358   fully sequenced,   358/358
(100 %)
2 diff
(99.5 %id)
H46218 brain .a 10255 to 10643 1 to 394       394/424
(92 %)
10 diff
(97.7 %id)
BY796069 eye .a 10256 to 10857 1 to 602       602/602
(100 %)
2 diff
(99.7 %id)
BQ009514 Chondrosarcoma, Left Pubic Bone .a 10277 to 10944 684 to 17   AAA   668/668
(100 %)
0 diff
(100 %id)
BG030513 breast, mammary adenocarcinoma, cell line .a 10282 to 10951 1 to 664       664/685
(96 %)
23 diff
(96.7 %id)
BQ182969 Chondrosarcoma, Left Pubic Bone .a 10284 to 10954 689 to 19   AAA   671/671
(100 %)
0 diff
(100 %id)
BQ377916 uterus .a 10303 to 10599 1 to 301       301/301
(100 %)
17 diff
(94.4 %id)
BU732601 eye, optic nerve .a 10318 to 10954 655 to 19   AAA   637/637
(100 %)
0 diff
(100 %id)
BM671267 eye, optic nerve .a 10318 to 10954 655 to 19   AAA   637/637
(100 %)
1 diff
(99.9 %id)
CB054269 brain, glioblastoma (pooled) .a 10400 to 10954 580 to 26   fully sequenced, AAA   555/555
(100 %)
1 diff
(99.9 %id)
AA010039 heart .a 10463 to 10945 485 to 1       485/486
(99 %)
4 diff
(99.2 %id)
W74640 heart .a 10473 to 10945 470 to 1   fully sequenced,   470/470
(100 %)
4 diff
(99.2 %id)
AA009527 heart .a 10477 to 10954 479 to 1       479/479
(100 %)
1 diff
(99.8 %id)
AW150206 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 10492 to 10954 464 to 1       464/464
(100 %)
2 diff
(99.6 %id)
AI683825 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 10507 to 10949 449 to 7       443/449
(98 %)
0 diff
(100 %id)
AA878400 carcinoid, lung .a 10526 to 10954 429 to 1       429/429
(100 %)
1 diff
(99.8 %id)
AA037005 uterus .a 10530 to 10947 430 to 1       430/430
(100 %)
12 diff
(97.3 %id)
AI935962 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 10537 to 10947 434 to 24   AAA   411/411
(100 %)
5 diff
(98.8 %id)
BE671379 carcinoid, lung .a 10537 to 10949 415 to 3       413/415
(99 %)
0 diff
(100 %id)
AI264271 Kidney .a 10555 to 10954 414 to 15   AAA   400/400
(100 %)
0 diff
(100 %id)
DB320875 Kidney .a 10557 to 10954 401 to 2       400/401
(99 %)
0 diff
(100 %id)
AL536150 brain, fetal brain .a 10608 to 10929 321 to 1       844/913
(92 %)
40 diff
(95.7 %id)
AI651669 pooled germ cell tumors .a 10616 to 10949 334 to 1       334/334
(100 %)
1 diff
(99.8 %id)
AI990892 pooled germ cell tumors .a 10616 to 10947 332 to 1       332/332
(100 %)
0 diff
(100 %id)
R40343 whole brain .a 10649 to 10944 313 to 12   AAA   302/306
(98 %)
6 diff
(98.1 %id)
AI471095 brain, glioblastoma (pooled) .a 10740 to 10954 215 to 1       215/215
(100 %)
0 diff
(100 %id)
BU566283 mixed (pool of 40 RNAs) .a 10749 to 10945 1 to 197   AAA   197/197
(100 %)
4 diff
(98.0 %id)
AA046238 uterus .a 10756 to 10954 210 to 11   AAA   200/203
(98 %)
1 diff
(99.6 %id)
BF090457 nervous_tumor .a 10821 to 11019 1 to 195   tiling clone,   195/198
(98 %)
6 diff
(97.0 %id)
BM127679 Islets of Langerhans, Pancreas .b 1 to 520 40 to 559   tiling clone,   523/567
(92 %)
6 diff
(99.0 %id)
CF594241 Human Placenta, placenta .b 345 to 1115 29 to 802   tiling clone,   774/826
(93 %)
11 diff
(98.7 %id)
BE149683 head_neck .b 472 to 959 497 to 11     Submitted on the opposite strand 487/499
(97 %)
6 diff
(98.8 %id)
AW501834 lymph .b 492 to 617 2 to 127       126/127
(99 %)
6 diff
(95.3 %id)
CD742661 Alveolar Macrophage, lung .b 949 to 1546 616 to 19   tiling clone, AAA   598/598
(100 %)
2 diff
(99.7 %id)
BM127374 Islets of Langerhans, Pancreas .b 989 to 1546 576 to 19   AAA   558/558
(100 %)
5 diff
(99.2 %id)
BX092567 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .b 1088 to 1548 475 to 15   AAA Submitted on the opposite strand 461/461
(100 %)
0 diff
(100 %id)
AI536870 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .b 1223 to 1549 330 to 4   tiling clone,   327/330
(99 %)
2 diff
(99.4 %id)
BU172661 melanotic melanoma, skin .c 1 to 846 4 to 857       854/859
(99 %)
34 diff
(96.1 %id)
BC036947 Breast, mammary adenocarcinoma. .c 6 to 4248 27 to 4269   tiling clone, available from MGC, AAA   4243/4243
(100 %)
1 diff
(100.0 %id)
TI_57189042   .c 6 to 852 52 to 893       842/842
(100 %)
23 diff
(97.3 %id)
BI859703 breast, mammary adenocarcinoma, cell line .c 8 to 852 1 to 840       840/840
(100 %)
23 diff
(97.3 %id)
BG281322 melanotic melanoma, skin .c 13 to 903 1 to 895       895/914
(97 %)
15 diff
(98.4 %id)
BG574260 breast, mammary adenocarcinoma, cell line .c 14 to 650 1 to 637       637/638
(99 %)
1 diff
(99.9 %id)
BQ878502 melanotic melanoma, cell line, skin .c 28 to 698 83 to 752   AAA   670/943
(71 %)
24 diff
(97.5 %id)
BU185533 melanotic melanoma, cell line, skin .c 29 to 725 1 to 699       699/971
(71 %)
9 diff
(99.1 %id)
BE277141 melanotic melanoma, skin .c 32 to 808 1 to 775       775/775
(100 %)
7 diff
(99.1 %id)
BE389294 endometrium, adenocarcinoma cell line, uterus .c 32 to 685 1 to 654       654/694
(94 %)
25 diff
(96.4 %id)
BE276542 melanotic melanoma, skin .c 33 to 467 1 to 436   available from MGC,   436/438
(99 %)
2 diff
(99.6 %id)
BE386687 melanotic melanoma, skin .c 39 to 705 11 to 678       668/719
(92 %)
11 diff
(98.5 %id)
DB293163   .c 1462 to 2198 2 to 739   tiling clone, capped   738/740
(99 %)
9 diff
(98.8 %id)
DB293037   .c 3108 to 3857 2 to 760   capped   759/770
(98 %)
19 diff
(97.6 %id)
AL512709 melanoma (MeWo cell line) .c 3675 to 8595 51 to 4967   tiling clone, available from DKFZ, AAA   4917/4967
(98 %)
6 diff
(99.9 %id)
BC080571 Lung, epidermoid carcinoma .c 4086 to 6368 1 to 2289   available from MGC, AAA   2289/2289
(100 %)
15 diff
(99.4 %id)
AK000755   .c 4097 to 6526 1 to 2432   tiling clone, available from FLJ,   2432/2432
(100 %)
3 diff
(99.9 %id)
TI_59394154   .c 4437 to 4998 51 to 615       565/648
(87 %)
7 diff
(99.0 %id)
BM016532 breast, mammary adenocarcinoma, cell line .c 4438 to 5072 1 to 647       647/647
(100 %)
13 diff
(98.0 %id)
BU174853 ductal carcinoma, cell line, Pancreas .c 4458 to 5212 1 to 764       764/932
(81 %)
19 diff
(98.0 %id)
BQ685538 ductal carcinoma, cell line, Pancreas .c 4458 to 5228 1 to 777       777/923
(84 %)
26 diff
(97.2 %id)
BQ689412 ductal carcinoma, cell line, Pancreas .c 4458 to 5156 1 to 700       700/980
(71 %)
25 diff
(97.5 %id)
BF310069 muscle, rhabdomyosarcoma .c 4604 to 5162 1 to 560       560/560
(100 %)
3 diff
(99.5 %id)
AA176076   .c 4617 to 5192 1 to 570       570/576
(98 %)
34 diff
(94.1 %id)
BE791633 lung, small cell carcinoma .c 4620 to 5368 1 to 756       756/1130
(66 %)
17 diff
(98.5 %id)
DA380990 thalamus .c 4623 to 5183 2 to 563   capped   562/562
(100 %)
3 diff
(99.5 %id)
BE258269 eye, retinoblastoma .c 4770 to 5361 1 to 593   tiling clone,   593/594
(99 %)
17 diff
(97.2 %id)
BP310545 brain .c 4770 to 5357 1 to 592       592/592
(100 %)
20 diff
(96.7 %id)
CN300456 embryonic stem cells, DMSO-treated H9 cellline .c 4822 to 5514 8 to 703       696/703
(99 %)
6 diff
(99.2 %id)
AL157485 melanoma (MeWo cell line) .c 4858 to 6528 1590 to 3266   available from DKFZ, AAA   1677/3266
(51 %)
9 diff
(99.8 %id)
BG763173 melanotic melanoma, high MDR (cell line), skin .c 4858 to 5301 1 to 460       460/721
(63 %)
14 diff
(98.1 %id)
BM472608 melanotic melanoma, skin .c 4858 to 5582 13 to 751       739/977
(75 %)
28 diff
(97.2 %id)
CD629603   .c 4879 to 5227 357 to 15       343/357
(96 %)
0 diff
(100 %id)
BG334432 melanotic melanoma, skin .c 4879 to 5510 1 to 640       640/641
(99 %)
37 diff
(94.3 %id)
BG334438 melanotic melanoma, skin .c 4879 to 5350 1 to 481       481/695
(69 %)
19 diff
(97.3 %id)
BG476982 melanotic melanoma, skin .c 4879 to 5363 1 to 494       494/494
(100 %)
20 diff
(96.0 %id)
BE390496 endometrium, adenocarcinoma cell line, uterus .c 4900 to 5402 1 to 511       511/511
(100 %)
12 diff
(97.7 %id)
H15229 whole brain .c 4905 to 5287 1 to 383       383/494
(77 %)
5 diff
(99.0 %id)
BG030893 breast, mammary adenocarcinoma, cell line .c 4935 to 5630 1 to 720       720/743
(96 %)
15 diff
(98.0 %id)
BE897066 melanotic melanoma, skin .c 4956 to 5693 1 to 750       750/775
(96 %)
55 diff
(93.0 %id)
CN300457 embryonic stem cells, cell lines H1, H7, andH9 .c 4957 to 5497 1 to 547       547/547
(100 %)
8 diff
(98.6 %id)
CV025644 mixed .c 4964 to 5404 1 to 443       443/492
(90 %)
25 diff
(95.0 %id)
TI_1948089136   .c 4965 to 5404 132 to 573       442/911
(48 %)
2 diff
(99.8 %id)
DB220924 trachea .c 5008 to 5365 2 to 363   capped   362/362
(100 %)
4 diff
(98.9 %id)
BM915184 amelanotic melanoma, cell line, skin .c 5016 to 5848 17 to 860       844/1067
(79 %)
45 diff
(95.8 %id)
BM424152 amelanotic melanoma, cell line, skin .c 5021 to 5888 1 to 881       881/1038
(84 %)
20 diff
(98.1 %id)
EC473843 Prostate .c 5027 to 5142 1 to 110       110/114
(96 %)
11 diff
(90.4 %id)
BU147464 eye, normal pigmented retinal epithelium .c 5051 to 5692 1 to 656       656/989
(66 %)
38 diff
(96.2 %id)
CD629600   .c 5087 to 5204 127 to 11       117/127
(92 %)
0 diff
(100 %id)
BQ719437 sympathetic trunk .c 5087 to 5817 1 to 745       745/914
(81 %)
25 diff
(97.3 %id)
N48369.
matches multiple genes
melanocyte .c 5171 to 5281 1 to 111     also hits gene EIF2S3 111/111
(100 %)
2 diff
(98.2 %id)
BC014480 Skin, melanotic melanoma, high MDR. .c 5222 to 6528 704 to 2011   AAA   1308/2011
(65 %)
6 diff
(99.8 %id)
BE142190 head_neck .c 5225 to 5453 1 to 229       229/235
(97 %)
1 diff
(99.6 %id)
BG765096 melanotic melanoma, high MDR (cell line), skin .c 5234 to 5512 1 to 279   tiling clone,   279/279
(100 %)
1 diff
(99.7 %id)
BM710570 eye, RPE and Choroid .c 5235 to 5845 1 to 613       613/613
(100 %)
7 diff
(98.9 %id)
CX865464 embryonic stem .c 5262 to 6027 1 to 768       768/768
(100 %)
7 diff
(99.1 %id)
BM725493 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .c 5277 to 5825 1 to 549       549/549
(100 %)
5 diff
(99.1 %id)
BP381583 adipose tissue .c 5285 to 5904 1 to 620       620/620
(100 %)
6 diff
(99.1 %id)
BQ228191 epithelioid carcinoma, Pancreas .c 5304 to 6204 1 to 919       919/931
(98 %)
39 diff
(95.9 %id)
BG281596 melanotic melanoma, skin .c 5330 to 5512 1 to 183       183/183
(100 %)
3 diff
(98.4 %id)
BG478176 melanotic melanoma, skin .c 5330 to 5512 1 to 183       183/183
(100 %)
2 diff
(99.0 %id)
BG477309 melanotic melanoma, skin .c 5330 to 5512 1 to 184       184/184
(100 %)
3 diff
(98.4 %id)
BE274741 melanotic melanoma, skin .c 5351 to 5492 1 to 141       141/141
(100 %)
1 diff
(99.3 %id)
BM014834 breast, mammary adenocarcinoma, cell line .c 5374 to 6137 1 to 760       760/761
(99 %)
12 diff
(98.5 %id)
TI_59392904   .c 5374 to 6137 47 to 806       760/761
(99 %)
12 diff
(98.5 %id)
BQ436977 melanotic melanoma, skin .c 5420 to 6147 1 to 735       735/922
(79 %)
25 diff
(97.3 %id)
Z43145 brain, total brain .c 5438 to 5756 1 to 319       319/319
(100 %)
8 diff
(97.5 %id)
BI862391 breast, mammary adenocarcinoma, cell line .c 5445 to 6256 23 to 841   tiling clone,   819/841
(97 %)
6 diff
(99.3 %id)
TI_57191630   .c 5445 to 6256 144 to 962       819/841
(97 %)
6 diff
(99.3 %id)
BQ938748 epidermoid carcinoma, cell line, lung .c 5471 to 6197 1 to 733       733/995
(73 %)
16 diff
(98.4 %id)
T99660 liver and spleen .c 5480 to 5807 1 to 329       329/366
(89 %)
17 diff
(95.4 %id)
BM541754 leiomyosarcoma, uterus .c 5525 to 6286 30 to 796       767/1157
(66 %)
23 diff
(98.1 %id)
AW852109 colon .c 5563 to 5873 1 to 309       309/309
(100 %)
4 diff
(98.8 %id)
H27196 breast .c 5628 to 5993 1 to 373       373/376
(99 %)
16 diff
(95.8 %id)
BG469349 adenocarcinoma cell line, colon .c 5639 to 6383 1 to 744       744/853
(87 %)
22 diff
(97.5 %id)
BM798179 Ascites, stomach .c 5667 to 6033 1 to 367       367/367
(100 %)
4 diff
(99.0 %id)
BU188659 melanotic melanoma, cell line, skin .c 5678 to 6280 1 to 611       611/822
(74 %)
17 diff
(98.0 %id)
N29215 melanocyte .c 5689 to 6136 1 to 457   fully sequenced,   457/457
(100 %)
9 diff
(98.1 %id)
BU172224 melanotic melanoma, skin .c 5696 to 6365 5 to 674   AAA   670/698
(95 %)
5 diff
(99.3 %id)
AA333589 Embryo, 8 weeks .c 5701 to 6064 1 to 366       366/367
(99 %)
7 diff
(98.1 %id)
AW965371   .c 5702 to 6283 1 to 580       580/581
(99 %)
28 diff
(95.2 %id)
TI_154125017   .c 5702 to 6528 895 to 71   AAA   825/981
(84 %)
22 diff
(97.8 %id)
BE898055 melanotic melanoma, skin .c 5736 to 6360 1 to 623       623/623
(100 %)
15 diff
(97.6 %id)
H44806 breast .c 5748 to 6106 18 to 382       365/459
(79 %)
5 diff
(99.0 %id)
W94827 heart .c 5757 to 5953 1 to 197       197/197
(100 %)
2 diff
(99.0 %id)
BQ224315 melanotic melanoma, skin .c 5766 to 6363 1 to 598   AAA   598/598
(100 %)
3 diff
(99.5 %id)
TI_149278317   .c 5769 to 6526 843 to 86   AAA   758/1146
(66 %)
5 diff
(99.6 %id)
AI360669 pooled germ cell tumors .c 5794 to 6004 316 to 106   AAA   211/299
(70 %)
0 diff
(100 %id)
DB383101   .c 5800 to 6363 556 to 1       556/560
(99 %)
19 diff
(96.7 %id)
BU625131 cell lines, Enchondroma .c 5811 to 6363 571 to 19   AAA   553/553
(100 %)
23 diff
(95.9 %id)
TI_159704429   .c 5827 to 6529 837 to 139       699/1104
(63 %)
0 diff
(100 %id)
BM678128 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .c 5874 to 6528 671 to 17   AAA   655/655
(100 %)
6 diff
(99.1 %id)
BQ774488 Chondrosarcoma Grade II, Left Pelvis .c 5935 to 6528 612 to 19   AAA   594/596
(99 %)
4 diff
(99.4 %id)
N38732.
matches multiple genes
melanocyte .c 5939 to 6528 586 to 1     also hits gene EIF2S3 586/587
(99 %)
9 diff
(98.5 %id)
AI160356 heart .c 5947 to 6475 529 to 1       529/529
(100 %)
0 diff
(100 %id)
AI808093 pooled .c 5950 to 6475 526 to 1       526/526
(100 %)
1 diff
(99.9 %id)
AI884939 anaplastic oligodendroglioma, brain .c 5954 to 6475 522 to 1       522/522
(100 %)
0 diff
(100 %id)
BF439370 pooled .c 5962 to 6475 514 to 1       514/514
(100 %)
1 diff
(99.9 %id)
BU678400 lung .c 5963 to 6526 579 to 16   AAA   564/564
(100 %)
2 diff
(99.7 %id)
AI500230 anaplastic oligodendroglioma, brain .c 5965 to 6365 400 to 1       400/409
(97 %)
3 diff
(99.3 %id)
AI554045 pooled .c 5972 to 6475 504 to 1       504/504
(100 %)
0 diff
(100 %id)
CA415992 Chondrosarcoma Cell line .c 5984 to 6528 562 to 17   AAA   546/546
(100 %)
3 diff
(99.5 %id)
BQ773105 Chondrosarcoma Cell line .c 5984 to 6528 558 to 14   AAA   545/545
(100 %)
4 diff
(99.3 %id)
AI421299 brain, glioblastoma (pooled) .c 5990 to 6475 486 to 1       486/486
(100 %)
1 diff
(99.8 %id)
DB382975   .c 5993 to 6526 536 to 1       536/539
(99 %)
8 diff
(98.6 %id)
AW665539 pooled .c 6024 to 6475 452 to 1       452/452
(100 %)
0 diff
(100 %id)
CK299692 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .c 6038 to 6528 508 to 17   AAA   492/492
(100 %)
6 diff
(98.8 %id)
AA679310 liver and spleen .c 6046 to 6475 429 to 1       429/429
(100 %)
2 diff
(99.6 %id)
TI_151811761   .c 6047 to 6528 79 to 560   tiling clone, fully sequenced, AAA   482/482
(100 %)
0 diff
(100 %id)
AI347979 adenocarcinoma, colon .c 6051 to 6475 425 to 1       425/425
(100 %)
1 diff
(99.8 %id)
AA857995 adenocarcinoma, colon .c 6063 to 6475 412 to 1       412/412
(100 %)
3 diff
(99.3 %id)
AI419009 brain, glioblastoma (pooled) .c 6066 to 6475 410 to 1       410/410
(100 %)
1 diff
(99.8 %id)
AA916328 adenocarcinoma, colon .c 6068 to 6475 404 to 1       404/404
(100 %)
6 diff
(98.6 %id)
AA878892 2 pooled tumors (clear cell type), Kidney .c 6069 to 6475 406 to 1       406/406
(100 %)
2 diff
(99.6 %id)
AA975037 Kidney .c 6080 to 6475 393 to 1       393/393
(100 %)
5 diff
(98.8 %id)
AI244149 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .c 6083 to 6526 444 to 1       444/444
(100 %)
9 diff
(98.0 %id)
BI963013 Islets of Langerhans, Pancreas .c 6088 to 6364 1 to 277   AAA   277/277
(100 %)
1 diff
(99.7 %id)
BM021978 Islets of Langerhans, Pancreas .c 6088 to 6363 1 to 276       276/311
(88 %)
4 diff
(98.8 %id)
AW665526 pooled .c 6089 to 6474 387 to 2       386/387
(99 %)
0 diff
(100 %id)
BG751443 eye, normal pigmented retinal epithelium .c 6093 to 6701 1 to 610       610/920
(66 %)
16 diff
(98.3 %id)
AI146613 senescent fibroblast .c 6103 to 6475 373 to 1       373/373
(100 %)
1 diff
(99.8 %id)
N20519 melanocyte .c 6106 to 6526 418 to 1   fully sequenced,   418/418
(100 %)
7 diff
(98.4 %id)
AA503762 colon .c 6110 to 6475 363 to 1       363/371
(97 %)
4 diff
(99.0 %id)
AA114103   .c 6113 to 6475 365 to 1     Submitted on the opposite strand 365/365
(100 %)
5 diff
(98.7 %id)
BM719654 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .c 6119 to 6526 1 to 408   fully sequenced, AAA   408/408
(100 %)
5 diff
(98.8 %id)
AI636592 Kidney, renal cell tumor .c 6122 to 6527 407 to 2       406/407
(99 %)
0 diff
(100 %id)
BE327852 malignant melanoma, metastatic to lymphnode, skin .c 6122 to 6529 408 to 1       408/408
(100 %)
0 diff
(100 %id)
AA770522 pooled .c 6127 to 6475 348 to 1       348/348
(100 %)
1 diff
(99.8 %id)
AI815027 adenocarcinoma, Pancreas .c 6128 to 6530 410 to 8       403/410
(98 %)
0 diff
(100 %id)
BU734396 eye, RPE and Choroid .c 6131 to 6526 414 to 19   AAA   396/396
(100 %)
3 diff
(99.3 %id)
H15169 whole brain .c 6148 to 6528 415 to 29   AAA   387/391
(98 %)
11 diff
(97.2 %id)
AA905423 pooled .c 6153 to 6475 321 to 1       321/321
(100 %)
2 diff
(99.4 %id)
AA599744   .c 6157 to 6475 319 to 1       319/319
(100 %)
0 diff
(100 %id)
BM682943 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .c 6162 to 6526 381 to 16   fully sequenced, AAA   366/366
(100 %)
3 diff
(99.2 %id)
R65573 placenta .c 6171 to 6525 362 to 2       361/437
(82 %)
0 diff
(100 %id)
H27197 breast .c 6171 to 6519 365 to 11       355/384
(92 %)
0 diff
(100 %id)
AI869916 colon, colonic mucosa from 3 patients with Crohn'sdisease .c 6172 to 6475 305 to 1       305/305
(100 %)
2 diff
(99.4 %id)
AW316738 brain, three pooled meningiomas .c 6172 to 6516 345 to 1       345/345
(100 %)
3 diff
(99.2 %id)
AA641444 epithelium (cell line), Prostate .c 6173 to 6339 167 to 1       167/167
(100 %)
0 diff
(100 %id)
DA232229 brain .c 6181 to 6750 2 to 571   capped   570/570
(100 %)
2 diff
(99.7 %id)
M78706   .c 6185 to 6530 349 to 1       349/349
(100 %)
7 diff
(98.0 %id)
DA698212   .c 6189 to 6750 2 to 564   tiling clone, capped   563/563
(100 %)
2 diff
(99.7 %id)
AA176077   .c 6200 to 6475 274 to 1       274/274
(100 %)
2 diff
(99.3 %id)
AW006339 colon .c 6205 to 6464 271 to 12       260/271
(95 %)
0 diff
(100 %id)
F02618 brain, total brain .c 6209 to 6528 320 to 1       320/320
(100 %)
3 diff
(99.1 %id)
BE890038 leiomyosarcoma, uterus .c 6213 to 6939 1 to 722       722/976
(73 %)
32 diff
(96.8 %id)
AA693432   .c 6227 to 6475 247 to 1       247/247
(100 %)
2 diff
(99.2 %id)
AI479843 anaplastic oligodendroglioma, brain .c 6239 to 6363 151 to 27   AAA   125/125
(100 %)
1 diff
(99.2 %id)
F03410 brain, total brain .c 6245 to 6528 284 to 1       284/284
(100 %)
2 diff
(99.3 %id)
DA121913 cerebellum .c 6257 to 6790 2 to 535   capped   534/534
(100 %)
2 diff
(99.7 %id)
AI277066 adenocarcinoma, colon .c 6260 to 6475 216 to 1       216/216
(100 %)
1 diff
(99.6 %id)
W94828 heart .c 6266 to 6527 263 to 3       261/265
(98 %)
0 diff
(100 %id)
AI368515 anaplastic oligodendroglioma, brain .c 6282 to 6475 195 to 1       195/195
(100 %)
1 diff
(99.5 %id)
BG060164 brain, glioblastoma without EGFR amplification .c 6290 to 6528 239 to 1       239/239
(100 %)
15 diff
(93.8 %id)
C01871   .c 6368 to 6528 1 to 161       161/161
(100 %)
1 diff
(99.4 %id)
DA411428 thalamus .c 6389 to 6935 2 to 548   capped   547/547
(100 %)
1 diff
(99.9 %id)
AI146943 senescent fibroblast .c 6393 to 6475 81 to 1       81/81
(100 %)
2 diff
(97.6 %id)
Z21913   .c 6409 to 6594 1 to 186       186/202
(92 %)
5 diff
(97.6 %id)
Z21916   .c 6409 to 6612 1 to 204       204/204
(100 %)
12 diff
(94.2 %id)
TI_151731896   .c 6453 to 6528 156 to 80   fully sequenced, AAA   77/77
(100 %)
1 diff
(98.8 %id)
BM904573 leiomyosarcoma, uterus .c 6572 to 7286 1 to 720       720/1058
(68 %)
20 diff
(98.2 %id)
AL536151 brain, fetal brain .c 6719 to 7710 1 to 978       978/1037
(94 %)
28 diff
(97.3 %id)
DN997820 breast cancer, Mammary gland (cancer tissue) .c 6831 to 7438 1 to 608       608/608
(100 %)
5 diff
(99.2 %id)
BU188127 melanotic melanoma, skin .c 6882 to 7618 11 to 749       739/889
(83 %)
6 diff
(99.4 %id)
DA504930 brain .c 7082 to 7656 2 to 577   tiling clone, capped   576/576
(100 %)
4 diff
(99.4 %id)
BG762628 melanotic melanoma, high MDR (cell line), skin .c 7367 to 8200 1 to 836       836/837
(99 %)
13 diff
(98.5 %id)
BG768012 melanotic melanoma, high MDR (cell line), skin .c 7367 to 8067 1 to 701       701/703
(99 %)
9 diff
(98.8 %id)
BX431616 brain, fetal brain .c 7507 to 8131 1 to 631       631/1040
(60 %)
39 diff
(96.3 %id)
TI_59391765   .c 7565 to 8437 92 to 961   tiling clone,   870/872
(99 %)
12 diff
(98.7 %id)
BM013828 breast, mammary adenocarcinoma, cell line .c 7566 to 8437 1 to 869   available from MGC,   869/871
(99 %)
12 diff
(98.7 %id)
CB140414 Liver .c 7606 to 8027 1 to 422       422/422
(100 %)
1 diff
(99.8 %id)
BF765500 colon_est .c 7854 to 8179 18 to 343       326/343
(95 %)
6 diff
(98.3 %id)
CR936670 Spinal cord .d 1 to 5328 1 to 5326 exact tiling clone, AAA   4958/6395
(77 %)
34 diff
(99.5 %id)
BX361657   .e 1 to 945 1 to 952 L2P R3E D6G N8A G9T ... tiling clone,   951/952
(99 %)
44 diff
(95.4 %id)
BC001525 Skin, melanotic melanoma. .f 1 to 1141 1 to 1141 exact tiling clone, available from MGC, AAA   1141/1141
(100 %)
2 diff
(99.9 %id)
TI_227713648   .f 239 to 1141 998 to 104   tiling clone, AAA   895/975
(91 %)
20 diff
(98.0 %id)
BG576235 breast, mammary adenocarcinoma, cell line .f 300 to 1035 24 to 762       739/836
(88 %)
20 diff
(97.7 %id)
BQ188337 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .f 402 to 815 1 to 414   fully sequenced,   414/414
(100 %)
8 diff
(98.1 %id)
TI_151732177   .f 402 to 1141 809 to 72   AAA   738/892
(82 %)
19 diff
(97.9 %id)
CK299818 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .f 785 to 1141 377 to 19   tiling clone, fully sequenced, AAA   359/359
(100 %)
5 diff
(98.7 %id)
BI857176 breast, mammary adenocarcinoma, cell line .g 1 to 583 1 to 590   tiling clone,   591/590
(100 %)
25 diff
(95.8 %id)
TI_57186839   .g 1 to 583 75 to 664       591/590
(100 %)
25 diff
(95.8 %id)
BM557387 melanotic melanoma, skin .g 3 to 899 1 to 899   tiling clone,   899/976
(92 %)
11 diff
(98.9 %id)
BU156019 melanotic melanoma, skin .g 6 to 678 1 to 678       678/914
(74 %)
11 diff
(98.8 %id)
BG576220 breast, mammary adenocarcinoma, cell line .h 1 to 683 1 to 683   tiling clone,   683/683
(100 %)
2 diff
(99.8 %id)
BG760498 melanotic melanoma, high MDR (cell line), skin .h 20 to 733 1 to 715 Q204T L205T L206A Y207V L208P ... tiling clone,   914/926
(98 %)
23 diff
(97.6 %id)
BG762541 melanotic melanoma, high MDR (cell line), skin .h 20 to 736 1 to 718   tiling clone,   718/722
(99 %)
5 diff
(99.4 %id)
BG768556 melanotic melanoma, high MDR (cell line), skin .h 20 to 714 1 to 707       707/722
(97 %)
30 diff
(95.9 %id)
BG768769 melanotic melanoma, high MDR (cell line), skin .h 20 to 705 1 to 686       686/688
(99 %)
3 diff
(99.6 %id)
BM922829 leukocyte .i-u 1 to 604 1 to 605 A163T S181T C183W R184S D185E ... tiling clone,   605/1177
(51 %)
8 diff
(99.4 %id)
BG576856 breast, mammary adenocarcinoma, cell line .j 1 to 685 1 to 686 N139K P182A E188A K189E Q190T tiling clone,   686/687
(99 %)
4 diff
(99.5 %id)
BQ422384 melanotic melanoma, skin .k 1 to 713 12 to 739 Q91X tiling clone,   728/958
(75 %)
32 diff
(96.7 %id)
BX108289 anaplastic oligodendroglioma, brain .l 1 to 305 1 to 305 exact tiling clone,   305/305
(100 %)
0 diff
(100 %id)
AI939608 anaplastic oligodendroglioma, brain .l 51 to 613 562 to 1   tiling clone,   562/574
(97 %)
6 diff
(99.0 %id)
AI417389 anaplastic oligodendroglioma, brain .l 147 to 613 466 to 1   tiling clone,   466/466
(100 %)
1 diff
(99.8 %id)
DB061951 testis .m 1 to 555 2 to 557 V14X T16H G17R C18L V19R ... tiling clone, capped   554/556
(99 %)
1 diff
(99.9 %id)
BX648922 human testis .n 1 to 5268 1 to 5269 M149I tiling clone, available from DKFZ, AAA   5269/5269
(100 %)
6 diff
(99.9 %id)
BX489101   .n 53 to 331 1 to 279       279/280
(99 %)
19 diff
(93.3 %id)
TI_154070292   .o-u 1 to 287 1002 to 715   tiling clone,   288/542
(53 %)
0 diff
(100 %id)
AA531128 normal prostatic epithelial cells, Prostate .o-u 156 to 585 455 to 24 R14T R15P L16P C17L M18H ... tiling clone, AAA   432/433
(99 %)
4 diff
(99.1 %id)
AI376640 pooled .o-u 178 to 587 426 to 17 S28F AAA   410/410
(100 %)
4 diff
(99.1 %id)
AW137567   .o-u 220 to 587 385 to 18 exact tiling clone, AAA   368/368
(100 %)
0 diff
(100 %id)
BF738285 bladder_tumor Gene TBC1D16, variant not shown         Suspected internal deletion, this clone was ignored    
BF800160 colon_ins Gene TBC1D16, variant not shown         Suspected internal deletion, this clone was ignored    
BU535986 mixed (pool of 40 RNAs) Gene TBC1D16, variant not shown       AAA This clone was ignored    
DA708076   Gene TBC1D16, variant not shown       capped Suspected internal deletion, this clone was ignored    
CA429328 Cell Line, Chondrosarcoma Gene TBC1D16, variant not shown       AAA Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i-u, .j, .k, .l, .m, .n, .o-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes C